AlbemarleALB -1.56%75 EBITDA Margin % is 31.15% as of Mar. 2026, which is 39% above its 10-year median of 22.47. GuruFocus rates ALB with a GF Score™ of 75/100 and a GF Value™ of $83.50 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 1,584 Chemicals companies, Albemarle ranks better than 52.46% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Albemarle's EBITDA for the
three
months ended in Mar. 2026 was $445 Mil. Albemarle's Revenue for the
three
months ended in Mar. 2026 was $1,429 Mil. Therefore, Albemarle's EBITDA margin for the quarter that ended in Mar. 2026 was 31.15%.
Albemarle (NYSE:ALB) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Albemarle EBITDA Margin % Related Terms
Albemarle EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Albemarle's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Specialty Chemicals subindustry, Albemarle's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Albemarle EBITDA Margin % vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Albemarle's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Albemarle's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Albemarle (ALB) has a EBITDA Margin % of 31.15% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Albemarle and its competitors. This is 39% above median its historical median of 22.47. According to the industry distribution chart, Albemarle ranks #753 out of 1584 companies in the Chemicals industry, placing it in the top 47.5%.
Is Albemarle's EBITDA Margin % too high?
Albemarle's current EBITDA Margin % of 31.15% is 39% above median its 10-year median of 22.47. The Chemicals industry median EBITDA Margin % is 9.64. Albemarle's value of 31.15% is 223.3% above this industry median. Based on the distribution chart, Albemarle ranks #753 out of 1584 companies in the Chemicals industry, which is above the industry midpoint. Overall, Albemarle has a GF Score™ of 75/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Albemarle's EBITDA Margin % compare to LYB and DD?
According to the Chemicals industry distribution chart, Albemarle ranks #753 out of 1584 companies for EBITDA Margin %. This puts Albemarle in the upper half of its industry. The industry median EBITDA Margin % is 9.64. Albemarle's value of 31.15% is 223.3% above this benchmark. While the company's 10-year median is 22.47 vs. the industry median of 9.64, Albemarle has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Chemicals company?
The median EBITDA Margin % among Chemicals companies is 9.64, based on 1,584 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Albemarle's current EBITDA Margin % of 31.15% is 223.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Albemarle and its competitors. For the Chemicals industry, the median EBITDA Margin % is 9.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Albemarle's current EBITDA Margin % is 31.15%, which is 39% above median its own 10-year median of 22.47. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Albemarle stock overvalued right now?
Based on GuruFocus' analysis, Albemarle (ALB) is currently considered Significantly Overvalued. The stock's GF Value™ is $83.50, compared to a current price of $147.64 — trading 76.8% above its estimated fair value. The current EBITDA Margin % is 31.15%, which is 39% above median its 10-year median of 22.47 and 223.3% above the Chemicals industry median of 9.64. Albemarle's overall GF Score™ is 75/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Albemarle (ALB), the current EBITDA Margin % is 31.15% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Albemarle (ALB) Overvalued in 2026?
Based on GuruFocus' analysis, Albemarle stock appears to be overvalued.
The current stock price of $147.64 is trading 76.8% above its estimated GF Value™ of $83.50.
GuruFocus considers Albemarle to be Significantly Overvalued.
Key valuation signals for ALB:
EBITDA Margin %: 31.15% (39% above median its 10-year median of 22.47)
GF Value™: $83.50 vs. price of $147.64 (76.8% above fair value)
Industry Position: 223.3% above the Chemicals median (#753 of 1584)
No single metric tells the full story. See the ALB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Albemarle is one of the world's largest lithium producers. In the lithium industry, the majority of demand comes from batteries, where lithium is used as the energy storage material, particularly in electric vehicles. Albemarle is a fully integrated lithium producer. Its upstream resources include salt brine deposits in Chile and the US and two hard rock mines in Australia, both of which are joint ventures. The company operates lithium refining plants in Chile, the US, Australia, and China. Albemarle is a global leader in the production of bromine, used in flame retardants.
75GF Score
Get the complete analysis for ALB
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ALB has been successfully added to your 
